Aomics GmbH logo

Aomics GmbH

Aomics is a global clinical data science CRO specialising in delivering end-to-end clinical biometrics solutions to SMEs

4 employees · est. 2019 · Eschborn, Germany

VS
Magic Genomix logo

Magic Genomix

One Patient : One Treatment

7 employees · est. 2023 · Toulouse, France

Aomics GmbH is the older company (2019 vs 2023).

Side-by-Side Comparison

Aomics GmbH Magic Genomix
Founded
2019 older 2023
Headquarters
Eschborn, Germany Toulouse, France
Employees
4 7
Industry
AI, Biotechnology, Health Care Not tracked yet
Funding Stage
Grant Unknown
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
2 1
Services
Not tracked yet Genomic data analysis, Biomarker identification and stratification, Drug response signature analysis, Patient stratification for clinical trials, Magic X software and service offerings
Target Customers
Not tracked yet Pharmaceutical Industries, Biotech Companies, Healthcare Professionals, Clinical Researchers
Taxonomy
Immunotherapy, Immunoinformatics, Biometrics, Bioinformatics, Clinical Development, Oncology Research, Biostatistics, Pharmacovigilance, Precision Medicine, Healthcare Data Analysis, Clinical Trials, Translational Medicine Precision Oncology, DeepTech Startup, Genomic Instability Biomarkers, Personalized Cancer Treatment, Drug Development, Clinical Data Analysis, Biopsy Data Analysis, Chemotherapy Response Prediction, Soft Tissue Sarcoma, Ovarian Cancer, Lung Cancer, Breast Cancer, Targeted Therapy, Immunotherapy, Regulatory Approval
Website
aomics.com magic-genomix.com
Aomics GmbH logo

About Aomics GmbH

Aomics GmbH is a German startup that focuses on boosting immuno-oncology research with cost-efficient biometric solutions for SMEs. The company's slogan "Analytics-driven risk reduction in immunotherapy development" succinctly captures its mission. Aomics' approach to reducing risks in the rapidly e...

Magic Genomix logo

About Magic Genomix

Magic Genomix, founded in 2023 and headquartered in France, is a promising precision oncology deeptech startup. With the slogan "One Patient : One Treatment," the company is leveraging genomic instability biomarkers to revolutionize cancer treatment and mitigate risks in drug development. Their pro...

We will tell you when either one moves

BounceWatch watches Aomics GmbH and Magic Genomix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aomics GmbH and Magic Genomix — by email.

Frequently Asked Questions

Aomics GmbH — Aomics is a global clinical data science CRO specialising in delivering end-to-end clinical biometrics solutions to SMEs. Magic Genomix — One Patient : One Treatment. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aomics GmbH and Magic Genomix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aomics GmbH with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aomics GmbH on 14 Sep 2024, and Magic Genomix on 13 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy